Ainos Inc Warrant 2022-29.07.27 on Ainos AIMDW 深 滬
已收盤 08-01 16:00:00 美东时间
0.12
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.12
- 總市值 0
- 52周最高 0.371
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.025
- 委 比 55.97%
- 總股本 --
- 歷史最高 0.892
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.025
- 每 手 1
- 風險率 0.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on
07-16 20:09
Ainos Announces 5-Yr Distribution Partnership With Solomon Technology To Fast-Track Ainos' AI Nose Platform Into Asia's Key Manufacturing Sectors
AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and MoreSAN DIEGO, CALIFORNIA /
07-07 20:07
Ainos To Implement Consolidation Of Its Common Stock, Effective June 30, 2025
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025.
06-26 23:02
Ainos Concludes Growth Financing From Lind Partners
Maintaining robust financial runway after the prepayment Reinforcing Ainos' com...
2024-08-06 19:30
Ainos, Inc. Announces 1-For-5 Stock Consolidation
Ainos, Inc. (NASDAQ:AIMD, AIMDW)))) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and
2023-12-12 21:03
Ainos Announces Placement Of Initial $3M Tranche Of $10M Private Placement; Proceeds To Fund Company's Clinical Trials, Commercial Product Launch, And Working Capital; Initial Conversion Price Set At $1.50 Per Share
Proceeds to fund company's clinical trials, commercial product launch, and working capitalInitial conversion price set at $1.50 per shareSAN DIEGO, CA / ACCESSWIRE / September 25, 2023 / Ainos, Inc. (NASDAQ:AIMD,
2023-09-25 20:33
